Real world and Appalachian comparison of axicabtagene ciloleucel and lisocabtagene maraleucel in relapsed/refractory diffuse large B-cell lymphoma.

Authors: Stephen Lee Yu, Mohammed Abdulhaleem, Zainab Fatima, Laxmi Upadhyay, Jesse Thompson, Salah Ud Din Safi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e19003

Source: Full article


Abstract

e19003